Explain this page
Arphra AIPlain-English read on Sionna Therapeutics, Inc.’s valuationBusiness description
· company · SEC profileSionna Therapeutics, Inc.
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Founded
—
IPO
Feb 07, 2025
Employees
41
HQ
Waltham, MA
CEO
Michael Cloonan
CFO
—
Exchange
NASDAQ
Fiscal year
—
Identifiers
· company_identifiersCIK0002036042
CUSIP829401108
ISINUS8294011080
FIGISION US
LEI—